Stock EXAS EXACT SCIENCES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News Exact Sciences Corporation

Equities

EXAS

US30063P1057

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-17 pm EDT 		5-day change 1st Jan Change
63.22 USD -1.00% Intraday chart for Exact Sciences Corporation -14.10% -14.54%
Apr. 15 Sector Update: Health Care Stocks Advance Premarket Monday MT
Apr. 15 Exact Sciences Names Aaron Bloomer CFO MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sector Update: Health Care Stocks Advance Premarket Monday
MT
Exact Sciences Names Aaron Bloomer CFO
MT
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
BU
Exact Sciences Appoints Aaron Bloomer as Chief Financial Officer, Effective from May 15, 2024
CI
Exact Sciences Corporation Announces Executive Changes
CI
Exact Sciences Signs Debt Exchange Deal, Placement of Convertible Notes
MT
Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes
BU
Exact Sciences Corporation announced that it expects to receive $266.8 million in funding
CI
Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
BU
Exact Sciences Schedules First Quarter 2024 Earnings Call
BU
Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment
BU
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer
AQ
Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
BU
Exact Sciences Corp. Advances Development of Non-Endoscopic Oncoguard Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
CI
Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner
BU
Transcript : Exact Sciences Corporation - Special Call
The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study
BU
Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer
BU
Exact Sciences Insider Sold Shares Worth $287,500, According to a Recent SEC Filing
MT
Transcript : Exact Sciences Corporation Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 01:30 PM
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EXAS Stock
  4. News Exact Sciences Corporation